Lattanzi, Simona
Brigo, Francesco
Trinka, Eugen
Cagnetti, Claudia
Di Napoli, Mario
Silvestrini, Mauro
Article History
Received: 31 May 2018
Revised: 4 July 2018
Accepted: 9 July 2018
First Online: 8 August 2018
Compliance with Ethical Standards
:
: SL, CC, MDN, and MS declare no conflict of interest. FB has received speakers’ honoraria from Eisai and PeerVoice; payment for consultancy from Eisai; and travel support from Eisai, ITALFARMACO, and UCB Pharma. ET received speaker’s honoraria from UCB, Biogen, Gerot-Lannach, Bial, Eisai, Takeda, Newbridge, Sunovion Pharmaceuticals Inc., and Novartis; consultancy funds from UCB, Biogen, Gerot-Lannach, Bial, Eisai, Takeda, Newbridge, Sunovion Pharmaceuticals Inc., and Novartis; directorship funds from Neuroconsult GmbH; and commercial funds from Biogen, Novartis, and Bayer. E. Trinka’s Institution received grants from Biogen, Red Bull, Merck, UCB, European Union, FWF Österreichischer Fond zur Wissenschaftsförderung, and Bundesministerium für Wissenschaft und Forschung.
: This article does not contain any study with human participants performed by any of the authors.